Detalhe da pesquisa
1.
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers.
Breast Cancer Res
; 21(1): 150, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31878959
2.
Glutamine antagonists may KEAP lung cancer in check.
Sci Adv
; 10(13): eado7808, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536918
3.
Critical role of antioxidant programs in enzalutamide-resistant prostate cancer.
Oncogene
; 42(30): 2347-2359, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355762
4.
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress.
Nat Cancer
; 3(7): 866-884, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654861
5.
Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview.
Endocr Relat Cancer
; 28(2): R31-R46, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33263560
6.
Molecular mechanisms of enzalutamide resistance in prostate cancer.
Cancer Drug Resist
; 2(2): 189-197, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582713
7.
Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress.
Nat Cancer
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769429
8.
DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiae.
PLoS One
; 10(9): e0138085, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26375390